A. L. Aalders

Preoperative CA-125 predicts extra-uterine disease and survival in uterine papillary serous carcinoma patients

J. Hendriks, L. Massuger, J. Bulten, 2012, The International journal of biological markers.

Universal Tumor DNA BRCA1/2 Testing of Ovarian Cancer: Prescreening PARPi Treatment and Genetic Predisposition

M. C. Vos, I. Nagtegaal, L. Kooreman, 2019, Journal of the National Cancer Institute.

Impact of the COVID-19-pandemic on patients with gynecological malignancies undergoing surgery: A Dutch population-based study using data from the ‘Dutch Gynecological Oncology Audit’

W. van Driel, K. Overmars, D. Boll, 2022, Gynecologic Oncology.

Use of risk of malignancy index to indicate frozen section analysis in the surgical care of women with ovarian tumors

K. Kluivers, L. Massuger, P. Zusterzeel, 2016, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

Evaluation of the Risk of Malignancy Index in daily clinical management of adnexal masses.

K. Kluivers, L. Massuger, R. Samlal, 2010, Gynecologic oncology.

Evaluation of the Risk of Malignancy Index in daily clinical management of adnexal masses.

K. Kluivers, L. Massuger, R. Samlal, 2010, Gynecologic oncology.